Preventing Dementia and Cognitive Impairment: A Workshop

When: October 25, 2016 (8:00 AM Eastern)
Where: National Academy of Sciences Building (NAS Lecture Room) • 2101 Constitution Avenue, NW, Washington, DC 20418

Topics Aging, Biomedical and Health Research, Public Health
Activity: Committee on Preventing Dementia and Cognitive Impairment
Board: Board on Health Sciences Policy


Many organizations and individuals worldwide are interested in the state of the science on preventing Alzheimer’s disease and related dementias, mild cognitive impairment (MCI), and age-related cognitive decline (ARCD). To develop a better understanding of current scientific evidence, implications for public health messaging, and future research needs, the National Institute on Aging (NIA) asked the National Academies of Sciences, Engineering, and Medicine (the National Academies) to convene an expert committee to make recommendations that inform public health strategies and messaging on preventive interventions and recommendations for future research. To aid the Committee in its work, the NIA has asked the  Agency for Healthcare Research and Quality (AHRQ) to commission and oversee a systematic review—conducted by the Minnesota Evidence-based Practice Center (EPC)—of the evidence on interventions associated with preventing, slowing, or delaying the onset of clinical Alzheimer’s-type dementia and MCI, and delaying or slowing ARCD. Other dementias such as frontotemporal dementia, Lewy body dementia, and dementias with a clear etiology, e.g., incident stroke, AIDS, traumatic brain injury will be excluded from the analysis. Interventions targeting stroke risk factors are a priority in this study. To help inform the National Academies committee’s recommendations, this public workshop will bring together key stakeholders to provide input to the committee on the draft AHRQ report. The National Academies committee’s report is expected to be released in June 2017.

Workshop Objectives:

  • Collect reactions to the draft EPC systematic review on preventive interventions that might reduce the risk of developing clinical Alzheimer’s-type dementia and mild cognitive impairment, and slow or delay age-related cognitive impairment/decline. 
  • Explore the current state of evidence on preventive interventions and discuss areas where public health messaging might be warranted. 
  • Discuss promising, emerging data on interventions that did not meet the evidentiary standard of the systematic review, and identify gaps and areas for future research.

As of March 2016, the Health and Medicine Division continues the consensus studies and convening activities previously undertaken by the Institute of Medicine (IOM).

Previous Meetings for this Activity

Also of Interest